Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis

BACKGROUND: The national Network Genomic Medicine (nNGM) Lung Cancer provides comprehensive and high-quality multiplex molecular diagnostics and standardized personalized treatment recommendation for patients with advanced non-small cell lung cancer (aNSCLC) in Germany. The primary aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kästner, Anika, Kron, Anna, van den Berg, Neeltje, Moon, Kilson, Scheffler, Matthias, Schillinger, Gerhard, Pelusi, Natalie, Hartmann, Nils, Rieke, Damian Tobias, Stephan-Falkenau, Susann, Schuler, Martin, Wermke, Martin, Weichert, Wilko, Klauschen, Frederick, Haller, Florian, Hummel, Horst-Dieter, Sebastian, Martin, Gattenlöhner, Stefan, Bokemeyer, Carsten, Esposito, Irene, Jakobs, Florian, von Kalle, Christof, Büttner, Reinhard, Wolf, Jürgen, Hoffmann, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687333/
https://www.ncbi.nlm.nih.gov/pubmed/38034041
http://dx.doi.org/10.1016/j.lanepe.2023.100788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687333/
https://www.ncbi.nlm.nih.gov/pubmed/38034041
http://dx.doi.org/10.1016/j.lanepe.2023.100788

Ejemplares similares